Cargando…
Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
SIMPLE SUMMARY: We have proved here that a magnetic bead-based assay using lectins can be effectively applied for glycoprofiling of free prostate specific antigen (fPSA). Such a glycan-based biomarker improves the detection of prostate cancer (PCa) in the PSA grey zone, the discrimination between cl...
Autores principales: | Bertok, Tomas, Jane, Eduard, Bertokova, Aniko, Lorencova, Lenka, Zvara, Peter, Smolkova, Bozena, Kucera, Radek, Klocker, Helmut, Tkac, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602627/ https://www.ncbi.nlm.nih.gov/pubmed/33076457 http://dx.doi.org/10.3390/cancers12102988 |
Ejemplares similares
-
Avoiding unnecessary sentinel node biopsy
por: Jeffree, JS, et al.
Publicado: (2006) -
Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer
por: Tang, Qionghua, et al.
Publicado: (2022) -
Glycan signatures for the identification of cisplatin‐resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG)
por: Hires, Michal, et al.
Publicado: (2022) -
Carboxybetaine Modified Interface for Electrochemical
Glycoprofiling of Antibodies Isolated from Human Serum
por: Bertok, Tomas, et al.
Publicado: (2015) -
MXene-assisted organic electrochemical transistor biosensor with multiple spiral interdigitated electrodes for sensitive quantification of fPSA/tPSA
por: Zhu, Yi-Cheng, et al.
Publicado: (2021)